Hemptown USA, founded in 2014, is a prominent player in the agriculture industry, specializing in premium CBD and CBG products sourced from the fertile soils of Southern Oregon. The company's diversified cannabinoid offerings cater to the increasing global demand for such products, encompassing various points along the value chain and distributed through multiple sales channels. Leveraging state-of-the-art cultivation facilities in Oregon’s Rogue Valley and an FDA-licensed, cGMP certified manufacturing process, Hemptown aims to capitalize on opportunities in the consumer-packaged goods sector by introducing high-quality white label and branded product lines targeting the consumer market. The strong leadership team, with extensive experience in Fortune 500 companies, is a key underpinning of Hemptown’s ambitious growth strategy.
In May 2019, Hemptown secured a substantial $23.30M investment in a venture round, signaling a vote of confidence from investors in the company's potential. This injection of capital is poised to fuel the company's expansion efforts and bolster its market presence. With its headquarters in the United States, Hemptown USA is strategically positioned to capitalize on the burgeoning market for cannabinoid-based products, presenting an intriguing prospect for venture capitalists seeking exposure to this rapidly evolving industry.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | $23.30M | - | 14 May 2019 |
No recent news or press coverage available for Hemptown USA.